Scripta Therapeutics Information

Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology. We aim to discover and develop therapeutics for neurodegenerative disorders. We are following a unique strategy, based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of disease. Therapeutics that modulate these maps to restore the healthy cell state can be efficiently identified by a data-rich, lab-in-the-loop combination of experimental biology with cutting-edge AI and informatics.